- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bombay HC Grants Conditional Bail to Pharma Manager in Rs 1.25 Crore Suspected Mephedrone Case

Aurangabad: A 57-year old environment, safety, and health manager at a multinational pharmaceutical company has been granted conditional bail by the Bombay High Court, in a high-profile suspected mephedrone seizure case.
Justice Sanjay Deshmukh ordered Kishor Pawar's (57), in Waluj MIDC release on a ₹50,000 personal bond, with strict instructions not to tamper with evidence or influence witnesses.
As per a media report in the Times of India, Pawar was arrested in June when police intercepted trucks carrying scrap material and reportedly recovered 2.5 kg of suspected mephedrone valued at ₹1.25 crore. An additional 961 grams of a similar substance were allegedly found at the company’s warehouse. He is the first among six accused to secure bail in the ongoing investigation.
The defence team, led by Rohit Kochar along with Abhaysinh Bhosale and Nachiketa Goyal, argued that Pawar was not named in the FIR and no narcotics were recovered from his personal possession. They emphasized that the company manufactures only export-oriented antihypertensive drugs. Forensic reports reportedly identified the seized powder as Valsartan and Hydrochlorothiazide, legitimate pharmaceutical ingredients rather than banned substances.
Also Read: Chhattisgarh HC denies bail in Rs 411 crore Medical Equipment Scam
The legal team also pointed out procedural irregularities during the investigation, such as the absence of a magistrate during sample collection, lack of videography, and delays in forensic lab reports, arguing that these lapses weakened the case against Pawar.
Times of India reports that the bail order highlights growing judicial scrutiny over narcotics-related investigations, especially where procedural and testing lapses raise doubts about the authenticity of alleged drug seizures.
The investigation continues, with five other accused still in custody.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751